Clinical Trials Logo

Head Pain clinical trials

View clinical trials related to Head Pain.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05712655 Completed - Head Pain Clinical Trials

Masticatory Muscles Electromyography in Post-pubertal Females With Forward Head Posture and Temporomandibular Disorders

Start date: July 1, 2021
Phase:
Study type: Observational

The aim of this study was to evaluate masticatory muscle electrical activity in post-pubertal females with forward head posture (FHP) and temporomandibular disorders (TMD) as well as in post-pubertal females with neutral head posture and with no temporomandibular disorders.

NCT ID: NCT04151576 Completed - Pain Clinical Trials

Aromatherapy Massage in Migraine Attacks

Start date: December 1, 2016
Phase: N/A
Study type: Interventional

The aim of the study was to determine the effect of aromatherapy massage on the pain severity and quality of life in patients diagnosed with migraine in addition to medical treatment during an acute migraine attack. In addition to medical treatments, complementary and supportive therapies are commonly used to cope with pain during a migraine attack. In recent years, aromatherapy through massage has become more common to reduce the severity of pain, make the patient painless and improve the quality of life. Aromatherapy applications are the application of pain relief oil mixtures through massage. Lavender and peppermint essential oils are mostly used in aromatherapy applications to reduce pain. Therefore, a mixture of mint and lavender oil was used in the study.

NCT ID: NCT04138316 Completed - Migraine Clinical Trials

CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study

CandeSpartan
Start date: January 2, 2020
Phase:
Study type: Observational [Patient Registry]

Observational, prospective, descriptive, open study on response predictors and tolerability of Candesartan in patients >18 years with episodic or chronic migraine with prior failure of three or more preventive drugs. Patients will receive Candesartan the same manner and intensity if they were not enrolled in the study. Vital signs, clinical variables and adverse events will be monitored. Primary endpoint will be to determine demographic and clinical factors associated with a 50% reduction in the frequency of headache days per month between weeks 20 and 24 compared with baseline.

NCT ID: NCT01174901 Completed - Head Pain Clinical Trials

Copeptin for Risk Stratification in Non-traumatic Headache in the Emergency Setting - The CoHead Study

CoHead
Start date: October 2010
Phase: N/A
Study type: Observational

Headache is a common symptom, and patients often seek medical attention at emergency departments due to headaches. The aim of the CoHead Study is to find out if it is possible by measuring copeptin, a marker of stress in the blood, to find out which patients have simple headaches and which patients have dangerous headaches that are the symptom of an underlying disease and need further investigation and treatment. Copeptin is a marker for physical stress and has been tested in patients with stroke, heart attack and pneumonia. In all these illnesses, the patients with the most serious forms had the highest levels of copeptin, while the ones with only mild presentation or no affection at all had the lowest levels of copeptin. The investigators expect to show the same in patients with headaches.

NCT ID: NCT01054378 Completed - Neck Pain Clinical Trials

Diaphragmatic Movement Before and After Stellate Ganglion Block : A Ultrasonographic Study

Start date: January 2010
Phase: Phase 4
Study type: Interventional

The temporary diaphrgmatic dysfunction will occur after stellate ganglion block(SGB) and will be easily detected by M-mode ultrasonography

NCT ID: NCT00297375 Completed - Migraine Clinical Trials

A Study Comparing the Effectiveness and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Treatment of Acute Pain From a Migraine Headache

Start date: April 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of tramadol HCl/acetaminophen as a pain medication compared with placebo in the treatment of acute pain from a migraine headache. Although tramadol HCl/acetaminophen is approved to treat acute pain, it is not approved for the treatment of acute pain associated with migraine headache. The study hypothesis is that tramadol HCl/acetaminophen is safe and effective as a pain medication in the treatment of acute pain associated with a migraine headache.